Clinical Trial

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Study acronym: APOLLO
Recruiting
View on ClinicalTrials.gov →
Summary
Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.
Protocol Amendment History 83 amendments
This ClinicalTrials.gov record has been amended 83 times since 2017-08-03; most recent amendment 2026-06-26.
Status change: Active, Not Recruiting → Recruiting 2020-06-08
Status change: Recruiting → Active, Not Recruiting 2020-04-27
Status change: Withheld → Recruiting 2017-11-11
Trial Details
NCT Number NCT03242642
Lead Sponsor Medtronic Cardiovascular
Conditions Mitral Valve Regurgitation
Enrollment 1,056 participants
Start Date 2017-10-23
Primary Completion 2027-05-30 (estimated)
Study Completion 2036-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-05